 Qubole | | |
 Queenly | | |
 Quell | Company operating in Gaming. | |
 Quell Therapeutics | Quell Therapeutics operates in Biotech & Life Sciences. | |
 Quench | Company operating in AI. | |
 QuEra | Hardware & Semiconductors company. | |
 Quero Education | | |
 Querypie Inc | QueryPie provides an enterprise access-control and agentic-AI platform for securely connecting data, systems and AI workflows with governance and audit controls. | |
 Quest Portal | Company operating in Gaming. | |
 QuestDB | | |
 Questflow | Company operating in Fintech. | |
 Questt | Questt operates in Education. | |
 Quibim | Medical imaging company developing AI software that converts MRI, CT and PET scans into quantitative biomarkers and predictions for clinical care and drug development. Its products include QP-Brain for measuring brain atrophy and neurological lesions, QP-Prostate for prostate cancer assessment, QP-Liver for liver tissue analysis, and QP-Insights for managing and analysing imaging and other data in clinical trials. Quibim supplies software platforms to hospitals and works with life sciences companies to develop and validate imaging biomarkers for precision medicine. Its multidisciplinary team spans radiology, AI engineering, clinical studies, regulatory affairs and commercial operations. | |
 Quick Ride | | |
 Quid | AI market intelligence (formerly NetBase Quid). | Santa Clara, California |
 Quill | Developer Tools company. | |
 Quill Bills | | |
 QuillBot | Company operating in AI. | |
 Quilt | Climate & Energy company. | |
 Quilt Health | Quilt Health operates in Healthcare. | |
 Quilter | Quilter operates in Manufacturing. | |
 Quince | Direct-to-consumer apparel. | San Francisco, California |
 Quince Therapeutics | Clinical-stage biotechnology company developing treatments for serious underserved diseases. Formerly Cortexyme, it is advancing LAM-001, an inhaled rapamycin candidate for pulmonary diseases, following its May 2026 acquisition of Orphai Therapeutics. Its earlier eDSP program used red-blood-cell drug encapsulation for ataxia-telangiectasia; the January 2026 Phase 3 study did not meet its primary endpoint. | |
 Quindar | | |
 Quino Energy | Quino Energy operates in Climate & Energy. | |
 Quintessent | Company operating in Hardware & Semiconductors. | |
 QuintoAndar | QuintoAndar operates in PropTech. | |
 Quiqup | On-demand delivery. | |
 Quirky | | |
 Quix | Company operating in AI. | |
 Quix Quantum | Hardware & Semiconductors company. | |
 Quizizz | Company operating in Education. | |
 Qumata | | |
 Quo | Mortgage access. | |
 Quoherent | Company operating in Hardware & Semiconductors. | |
 Quora | Quora operates in Social & Community. | |
 Quortex | Media & Entertainment company. | Lawrenceville, GA, USA |
 Quoter | Provides cloud quote-to-cash software for managed service providers and other technology businesses. It automates product catalogs, proposal creation, approvals, contracts and payments to reduce quoting errors and speed up sales. ScalePad acquired Quoter in October 2023 and offers it as part of its MSP platform. | |
 QurAlis | QurAlis Corporation is a Cambridge, Massachusetts biotechnology company developing precision medicines for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and other neurodegenerative diseases. Its research combines disease genetics, patient-derived stem-cell models and biomarkers with small-molecule and antisense oligonucleotide therapies. Its FlexASO platform develops splice-modulating antisense compounds; clinical programmes include QRL-201 and QRL-101. The company is relevant to neuroscience and advanced biotechnology; no unsupported artificial-intelligence claim is made.
The current own team page, modified September9,2026, publishes seven executives, nine board members, eight scientific advisers and five clinical advisers, representing28 distinct people. Kasper Roet serves as CEO and board member; Kevin Eggan and Clifford Woolf also have explicit founder affiliations. An obsolete hidden Jinsy Andrews modal is not treated as current roster membership. Manoj Malhotra is the current CMO, superseding older Doug Williamson announcements. One published adviser modal incorrectly reuses Manoj’s photo; Ammar Al-Chalabi’s authentic original portrait is instead verified against his own King’s College London biography. Shared people’s biographies, portraits and external affiliations are preserved.
Primary financing includes an undisclosed-size seed round reported April5,2018, USD42million SeriesA announced May13,2020, and USD88million SeriesB closed March9,2023. Cumulative totals are not additional rounds. A June3,2024 Lilly agreement combines an upfront USD45million licensing payment with a separately stated equity investment of undisclosed amount; the licensing payment and potential USD577million future milestones are not equity fundraising. ALS Association research awards are recorded separately from private investment. The2017 Amgen Golden Ticket provided laboratory space and services, not an inferred cash financing.
SEC filings identify the Delaware corporation, incorporated in2016 (CIK1811817). Separate convertible-promissory-note offerings reported USD5million securities sold in2022 and USD19,952,387 in2025; their targets of USD10million and USD24,921,734 are not completed raises. The cash fields remain unquantified pending reconciliation of note conversions with later equity financing. SeriesA andB SEC snapshots describe those same offerings and are not extra rounds. The March2026 corporate presentation explicitly described SeriesC funding as pending. | Cambridge, Massachusetts, United States |
 Qure.ai | | |
 Quri | Quri operates in Fintech. | |
 QurieGen | QurieGen develops single-cell multi-omics technology and AI models that help pharmaceutical and biotechnology companies understand disease mechanisms and predict how cells respond to drugs. Its QuRIE-seq platform measures RNA and multiple protein signals within the same cell over time, generating experimental data for AI Virtual Cell models. The Radboud University spin-off combines laboratory experiments with computational modelling to identify targets, explain drug responses and reduce uncertainty in drug discovery. | |
 QuVa Pharma | | |
 QV Bioelectronics | QV Bioelectronics operates in Healthcare. | |
 Qventus | Qventus operates in Healthcare. | |
 Qwilr | Qwilr is a modern proposal and quoting platform that turns sales documents into interactive web pages with e‑signature, payments, and detailed analytics, connected to CRMs like Salesforce and HubSpot. Founded in Sydney in 2014, it helps B2B teams move faster and win more deals. | 🇦🇺 · Australia |
 Qwilt | Qwilt operates in Infrastructure & Cloud. | |
 R1 | | |
 R1 RCM | | |
 R2 | Robotics & Automation company. | |
 r2c | | |
 RAAPID | RAAPID, Inc. develops healthcare AI software for medical coding and risk adjustment. Its platform combines neural models with medical knowledge graphs and clinical rules to interpret unstructured records, identify diagnoses and support traceable coding decisions for health plans, accountable-care organizations and providers. It addresses retrospective chart review, prospective care gaps and audit workflows across value-based care programs. The company is headquartered in Louisville, Kentucky and publishes founders Chetan Parikh and Vatsal Ghiya plus additional commercial and consulting leaders. Primary releases document M12 Series A financing in January 2025, an additional UPMC Enterprises Series A investment in March 2026, and a strategic Healthworx tranche in April 2026; individual and aggregate financing amounts are undisclosed. Neuro-symbolic AI describes its software architecture and does not establish a neuroscience therapeutic business. Earlier clinical-data and transcription milestones precede the founders’ stated 2022 RAAPID launch; corporate legal formation date remains unverified. | Louisville, Kentucky, United States |
 Rabbet | | |
 Rabot Charge | Rabot Charge operates in Climate & Energy. | |
 Rabot Energy | German energy supplier using AI to optimize dynamic electricity tariffs and electric-vehicle charging. Its software coordinates customer generation, electricity procurement and automated intraday-market trading to manage household energy costs. | |
 Rachio | Rachio makes connected irrigation controllers and outdoor watering products. Its app and weather-aware scheduling help homeowners manage lawn and garden watering while reducing unnecessary water use. | |
 Rad AI | AI software that drafts radiology impressions and automates reporting workflows. | Berkeley, California |
 RADAR | RADAR operates in Data & Analytics. | |
 Radar Relay | | |
 Radial | | |
 Radial Health Incubation | Access fast-acting, evidence-based treatments for depression, PTSD, and more — including TMS and Spravato® — covered by most insurance plans. | |
 Radiant | Portable nuclear microreactors (Kaleidos). Founders Fund joined Series B and later rounds. | El Segundo, California |
 Radiant | Portable nuclear microreactors (Kaleidos). Founders Fund joined Series B and later rounds. | El Segundo, California |
 Radiant Entertainment | | |
 Radiant Industries | Radiant develops factory-built, transportable nuclear microreactors intended to replace diesel generators for defense, disaster response, remote industry and critical infrastructure. | |
 Radiant Nuclear | | |
 Radiant Security | | |
 Radiant Security | | |
 Radical | Company operating in Healthcare. | |
 Radical Aero | | |
 Radical Catheter Technologies | Medical-device company developing endovascular access and delivery catheters for neurovascular procedures. Its ribbon-based catheter construction combines flexibility, pushability and stability for navigating complex blood-vessel anatomy. Co-founded by Martin Dieck and Brian Martin. | |
 Radical Health | | |
 Radionetics Oncology | Biotech & Life Sciences company. | |
 Radius Intelligence | | |
 RadixArk | RadixArk operates in AI. | |
 Raidium | Raidium builds radiology foundation models and AI tools that help radiologists analyze medical images and produce diagnostic reports. | |
 Railway | Company operating in Infrastructure & Cloud. | |
 Rain | Digital-asset authorization, settlement, and payment cards. Founded 2021. Los Angeles. | Los Angeles, California |
 Rain | | |
 Rain | | |
 Rainbow | Rainbow operates in Social & Community. | |
 Raindrop | Monitoring for AI applications and agents. Alerts engineers when models misbehave and links to the underlying conversations or traces. | San Francisco, California |
 Rainforest | Rainforest operates in E-Commerce & Marketplace. | |
 Rainmaker | | |
 RainThe blockchain-based card issuing platformPayments & RWA | Digital-asset authorization, settlement, and payment cards. Founded 2021. Los Angeles. | Los Angeles, California |
 Raise | Raise operates in Fintech. | |
 Raiseme | Education company. | |
 Raken | | |
 Rakurai | Company operating in AI. | |
 Rakuten Medical, Inc. | Healthcare company. | |
 Rally | Rally operates in Social & Community. | |
 Rally | | |
 Rally UXR | | |
 Rallyware | Workforce engagement, training and performance platform. | Mountain View, CA |
 Ralo | | |
 Ramani | | |
 Ramen | Ramen operates in Robotics & Automation. | |
 Ramen VR | Ramen VR is the San Francisco game-development and AI-agent company founded in 2019 by Andy Tsen and Lauren Frazier, operating at ramenvr.com through TribeVR Inc., a Delaware corporation (SEC CIK1788637). It was part of Y Combinator Summer2019 and originally developed the multiplayer VR game Zenith: The Last City. Its current Aura product is an AI agent integrated with Unity and Unreal Engine, including code and Blueprint work, editor operations, memory and verification/playtesting workflows. The March2026 acquisition of Coplay brought Unity AI tooling and its Unity MCP integration into Aura; the June2026 acquisition of Flopperam brought additional Unreal AI tooling and co-founder Chris Gong as Senior AI Engineer. Acquisition prices are undisclosed. Its September2026 Aura1.0 issuer release describes Anthropic Claude-based agents and Mac/Windows support. Productivity and game-market-coverage figures are company claims rather than independently established benchmarks. Current and historical named team affiliations are separately qualified; Lauren Frazier-Silva now identifies herself as founder of Silvermoon and is not presumed to remain current CTO. Ramen VR announced a USD35M SeriesB on17March2022 led by Anthos Capital and Dune Ventures with Makers Fund participation and personal checks from Andrew Chen and James Gwertzman, not an automatically inferred Andreessen Horowitz firm check. SEC filings separately document a single2021 offering with USD10,000,015 sold, and a2022 exempt-offering filing whose USD27,499,969 scope differs from the issuer’s35M headline; these are not summed into duplicate cash rounds. The2019 Zenith Kickstarter’s USD280,075 is pledged rewards crowdfunding, not venture equity. This company is distinct from ramennetworks.com and other Ramen businesses. | |
 Ramp | Corporate spend management and finance automation. Founded 2019 by Eric Glyman and Karim Atiyeh. HQ New York. Series F at $44B valuation in 2026. | New York, New York |
 Ramp 1 | Ramp is a financial operations platform combining corporate cards, expense management, bill payments, procurement, travel, banking and accounting automation. | |
 Ramp Financial | | |
 Ramp Network | Ramp Network operates in Fintech. | |
 Rancher | Company operating in Infrastructure & Cloud. | |
 Range | Social & Community company. | |
 RangeMe | E-Commerce & Marketplace company. | |
 Ranger | Ranger operates in Cybersecurity. | |
 Ranger AI | Company operating in Enterprise Software. | |
 RankScience | RankScience operates in Marketing & Advertising. | |
 Rapid Robotics | Rapid Robotics operates in Robotics & Automation. | |
 RapidAPI | RapidAPI operates in Developer Tools. | |
 RapidCanvas | RapidCanvas operates in AI. | |
 RapidFire.AI | Provides a deep-learning experimentation platform that runs and coordinates model variations across GPU resources, helping teams compare prompts, training settings and architectures. | |
 RapidFort | Attack-surface management and software hardening. | |
 RapidMiner | Data & Analytics company. | |
 RapidPulse | Develops a cyclic aspiration system for removing blood clots during treatment of ischemic stroke, intended to restore blood flow more completely and reduce disability. | |
 RapidSOS | Company operating in Government & Civic. | |
 Rappi | Operates an on-demand delivery marketplace connecting consumers with restaurants, grocery stores, pharmacies and other local merchants across Latin America. | |
 Rapport | | |
 Rapport Therapeutics | | |
 Rapport Therapeutics, Inc. | | |
 Rapportive | Rapportive operates in Enterprise Software. | |
 RAPsphere | | |
 Rapta | Rapta develops industrial AI and computer-vision systems for manufacturing guidance, inspection, quality assurance and production traceability. Its platform connects engineering, production and quality workflows and supports on-premises and air-gapped deployment for precision manufacturers, including aerospace, defense and medical-device businesses. Rapta is based in Lake Oswego, Oregon, and announced an East Coast headquarters in Cocoa Beach, Florida, in 2025. Its public team lists eight executives and five board roles, including founders Aaron J Brown, Matthew D Thornton and Matthias Daue. The company announced a $2.7 million seed round in June 2025 and an $8 million financing co-led by Voyager Capital and Access Venture Partners in September 2026. The September SEC filing reports a different equity-sold amount of $10,835,253, without explaining its relationship to the announced $8 million; it is retained as a disclosure rather than another financing. Rapta also received a $50,000 Space Florida Accelerating Innovation Award in June 2025 and was awarded $110,500 in investment commitments at the October 2025 Bend Venture Conference. Award terms and final disbursement are not independently established. | |
 Raptor Maps | | |
 Rapyd | Fintech company. | |
 RareCircles | Company operating in Social & Community. | |
 Rasa | Rasa operates in AI. | |
 Rasayel | SaaS company. | |
 Rascal Games | Rascal Games operates in Gaming. | |
 Rasgo | Company operating in AI. | |
 Raspberry AI | Raspberry AI operates in AI. | |
 RASPIRE | | |
 Rated | Rated operates in Crypto & Web3. | |
 Rattle | | |
 Raus | Raus operates in Travel & Hospitality. | |
 Ravelin Technology | Ravelin Technology operates in Cybersecurity. | |
 Raven | Company operating in AI. | |
 Raven Tech | | |
 RAVEN.IO | Company operating in Data & Analytics. | |
 Ravical | Company operating in AI. | |
 Ravio | Ravio operates in HR & Talent. | |
 Raw Pressery | | |
 Ray Browser | Ray Browser operates in AI. | |
 Ray Security | Company operating in Cybersecurity. | |
 Raycast | Raycast operates in Developer Tools. | |
 Raydiant | Raydiant operates in Marketing & Advertising. | |
 Rayon | Company operating in Developer Tools. | |
 Razor Group | Amazon brand aggregator, later merged with Perch. | Berlin, Germany |
 Razorpay | Full-stack payments and fintech for India. Founded 2013. Bengaluru. | Bengaluru, India |
 rct studio | | |
 RDash | | |
 Re:Build | Re:Build Manufacturing combines industrial design, engineering, operations and scalable domestic production to take complex products from concept through full-scale manufacturing. | Framingham, MA, US |
 Reach Industries | Builds visual AI systems for scientific laboratories and other regulated workplaces. Its Lumi platform uses computer vision to monitor experiments and equipment, capture laboratory activity, flag issues and generate records, helping scientists improve traceability and spend less time on manual observation and documentation. | |
 Reach Neuro | Neurotechnology company developing personalized cervical spinal-cord stimulation to restore arm and hand movement after stroke. Its approach uses implanted electrodes and a pulse generator to stimulate movement-related spinal circuits and is being developed through clinical research. | Providence, Rhode Island, US |
 Reactor | Developer platform for real-time world models and generative video inference. Founded in 2025 by Alberto Taiuti and Bryce Schmidtchen. San Francisco. | San Francisco, California |
 ReactWise | | |
 Readily | Readily is a San Francisco healthcare-compliance AI company building a unified platform for regulatory research, policy management, delegation oversight and audits. It links requirements, policies, contracts, reports and case files, analyzes audit evidence, identifies policies affected by regulatory changes and drafts revisions for expert review. It serves health plans and providers, including Medi-Cal managed-care organizations. Reported time, cost and audit-coverage improvements are company and investor case-study claims, not independently verified clinical outcomes. Edward Tiong is co-founder and CEO, and Wei An Wang is co-founder and CTO; those are the two active founders named by Y Combinator. Its directory reports20 team members but does not name the full staff. CHCF reports a2023 founding and YC records Summer2023 participation, while YC’s current Founded field says2024; the inconsistent2024 field is retained as a source discrepancy rather than treated as a separate company or financing event. California Health Care Foundation reports a USD1million program-related investment awarded in June2026. Its exact day, security instrument, round stage, terms and disbursement status are not disclosed. The company explicitly names Y Combinator, Define Ventures and CHCF as backers; SUTD’s own Venture Innovation Fund also lists Readily in its portfolio, linking the former readily.co domain that now redirects to readily.ai. No standard accelerator ticket or undisclosed seed total is inferred. Readily is relevant to healthcare AI and regulatory automation; reviewed sources do not establish a neuroscience therapeutic or neural-interface business. It is distinct from Swedish Readily Diagnostics, government-service company Readyly, Read AI and Indian Readily Solutions. Y Combinator’s August2024 launch and Ihsaan Patel’s own launch post also identify Patel as a co-founder alongside Edward Tiong. That historical affiliation is retained separately from the current active-founder list; no current Patel CEO office or departure date is inferred. | San Francisco, California, United States |
 Readme | Readme operates in Developer Tools. | |
 Ready | Support the community you love | |
 Ready Robotics | | |
 Ready.net | Ready builds an operating platform for local internet service providers, covering subscriber acquisition, onboarding, billing and integrations with legacy broadband systems. | |
 ready2order | Company operating in Fintech. | |
 ReadyPlayerMe | | |
 Readyset | Readyset operates in Developer Tools. | |
 Real | Real is a mental-wellness platform offering a member-centered therapy and self-care model designed to make mental-health support more affordable and accessible. | |
 RealCrowd | RealCrowd operates in Fintech. | |
 Reality Defender | Cybersecurity company. | |
 RealizedCare | RealizedCare is the acquired immersive digital-therapeutics business built around BehaVR, OxfordVR and Fern Health. Its products combine virtual reality, cognitive behavioral approaches and biopsychosocial care for chronic pain and behavioral-health conditions, with AI-supported care triage described by its acquirer. Historical BehaVR was founded in 2016 and filed as BehaVR LLC, later BehaVR Inc. OxfordVR combined with BehaVR alongside a USD13M Series B in December 2022; Fern Health joined the platform under the RealizedCare brand in 2023. These historical issuer and acquisition boundaries are qualified rather than treated as interchangeable independent funding recipients.
XRHealth announced the acquisition in February 2025 and appointed founder Aaron Gani general manager of XRHealth US. A September2026 buyer SEC filing identifies the seller as BehaVR Holdings Inc. (RealizedCare) and reports stock consideration for an asset purchase. That noncash transaction and a separately filed XRHealth loan are not represented as new RealizedCare financing. Current standalone leadership could not be verified from the inaccessible current company site; attached public leadership and scientific advisory affiliations are expressly historical or source-dated.
Verified financing includes a partial USD500K debt securities sale disclosed in2018, an adviser-confirmed completed USD10M2020SeriesA (with an earlier partial SEC disclosure qualified), and an actual USD13M2022SeriesB. Funding targets, undisclosed additional financing reported retrospectively, contingent licensing payments and academic research budgets are not added as cash raised. OxfordVR’s separate precombination capital history remains a distinct issuer research task. The 2021 Sumitomo digital-therapeutics licensing programme is qualified as a commercial development arrangement. FDA Breakthrough Device designation for OxfordVR technology is not FDA marketing approval. | United States |
 RealPact | | |
 Realta 2025-08-25 17.00.42-- | A baby star is born, in a simple cylinder ☀️ Realta’s magnetic mirror fusion reactor is small and modular, with a 50MW minimum efficient scale and lowest cost energy (aiming to be cheaper than natural gas). This allows it to be deployed at remote mining and industrial sites, distributed data cente… | |
 Realta Fusion | Company operating in Climate & Energy. | |
 RealtyShares | | |
 Reasoner | AI company. | |
 Rebag | E-Commerce & Marketplace company. | |
 Rebank | | |
 Rebank Technologies | | |
 Rebar | Develops AI tools that help HVAC suppliers read construction plans, prepare material estimates and manage quoting workflows. | |
 Rebellion | Company operating in Media & Entertainment. | |
 Rebellion Defense | Company operating in Defense & Space. | |
 Rebellions | Rebellions designs inference-focused AI semiconductors and complete data-center infrastructure for running large language models and multimodal AI. Its chiplet-based Rebel100 accelerator, RebelServer, RebelRack and RebelPOD systems combine purpose-built hardware with an open software stack to improve performance per watt and reduce deployment costs. Founded in South Korea in September 2020, Rebellions merged with SAPEON Korea in December 2024 and acquired inference optimization company SqueezeBits in June 2026. It serves commercial and sovereign AI infrastructure markets, with operations in Korea, the United States, Japan and Saudi Arabia. | |
 Rebellyous Foods | Manufactures plant-based meat at industrial scale using food-production equipment. | Seattle, Washington |
 Rebill | | |
 Rebrain | RebrAIn is a French medical-software company developing supervised AI-based, patient-specific MRI processing and brain-targeting tools for functional neurosurgery. Its legal issuer is Rebrain SAS, SIREN892511866, active since January1,2021 according to the French government register; its US operating affiliate Rebrain US Corp is identified separately on the same corporate website. Neurosurgeon Emmanuel Cuny and Inria applied-mathematics researcher Nejib Zemzemi co-founded the University Hospital of Bordeaux/Inria spin-off following academic research. Its OptimMRI software processes preoperative DICOM MRI images and helps qualified clinicians visualize and localize anatomical structures, including STN/VIM, alongside other clinical methods for neurosurgical planning. FDA records confirm ClassII 510(k) clearance K230150 on July21,2023 and OptimMRI(v2) K242054 on August12,2024; these are software device clearances, not drug approvals, autonomous treatment authorization or independent proof of clinical benefit. The company also reports European CE marking, with an independently retrieved CE certificate not available in this audit. Its current public directory identifies David Caumartin as CEO, Emmanuel Cuny as CMO/board president and Nejib Zemzemi as CSO/CTO, a strategic board and nine scientific/medical advisers. The statutory register separately identifies David Caumartin as Président de SAS and Cuny/Zemzemi as Directeurs Généraux. Additional people in its January2025 team announcement are recorded as dated affiliations where current operating titles cannot be confirmed. A completed EUR3.7M seed financing announced March18,2024 was led by Karista, joined by NACO and unnamed existing investors. Karista’s portfolio year2023 is not treated as a second priced cash event. Regional/EU programme support is reported without an invented amount or paid-cash grant; a171K technology-transfer maturation budget is not assumed paid to this legal company. Executive-career logos are not treated as investors. | Pessac, France · Cambridge, Massachusetts, United States |
 Rebulk AI | | |
 Rec Room | Gaming company. | |
 Recall | Recall operates in AI. | |
 Recapped | Enterprise Software company. | |
 Reclaim Security | Company operating in Cybersecurity. | |
 Reco | Reco operates in Cybersecurity. | |
 ReCode Therapeutics | Company operating in Biotech & Life Sciences. | |
 Recogni | Recogni operates in AI. | |
 RecommerceX | RecommerceX operates in Manufacturing. | |
 Reconnect Labs | Reconnect Labs is a Swiss clinical-stage biopharmaceutical company and University of Zurich spin-off developing drug candidates for psychiatric, sleep, neurological and metabolic conditions. Its harmine platform includes RE01, a next-generation psychedelic program for alcohol use disorder at Phase 2 entry, and IND-enabling RE04 and RE05 programs targeting diabetes/beta-cell regeneration and Parkinson’s disease through DYRK-1A-related mechanisms. It also develops RE03, an alpha-2 noradrenergic agonist program for PTSD with insomnia, and RE02, an IND-enabling serotonin-1A program for generalized anxiety disorder. A registered Phase 2 RE03 buccal-dexmedetomidine study in 12 PTSD patients completed in June 2026. These are investigational development programs; published clinical stages and study completion do not establish marketing authorization or proven clinical benefit. | Winterthur, Switzerland |
 Recora | Company operating in Healthcare. | |
 Recorded Future | Recorded Future operates in Cybersecurity. | |
 RecordGram | RecordGram, later Cre8tor.App, was a mobile recording studio, beat marketplace and social network that let aspiring artists create and share original songs and videos. | |
 Recraft | Recraft operates in Developer Tools. | |
 Recruitbot | HR & Talent company. | |
 RecruitmentSmart | Develops AI recruiting software that matches candidates to job descriptions, analyzes resumes and automates candidate screening and interview scheduling. | |
 Recurate | E-Commerce & Marketplace company. | |
 Recuro Health | | |
 Recurrency | Recurrency operates in Fintech. | |
 Recursion | Biotech & Life Sciences company. | |
 Recursion Pharmaceuticals | AI-driven drug discovery | |
 Recursive Superintelligence | Recursive Superintelligence develops AI systems designed to improve their own capabilities through recursive learning. | |
 Recycleye | Robotics & Automation company. | |
 Recyda | Company operating in SaaS. | |
 Red Balloon Security | | |
 Red Date Technology | Red Date Technology operates in Crypto & Web3. | |
 Red Hot Labs | | |
 Red Metals | Next generation manufacturing of high-conductivity copper. Faster, cleaner, and built in America. From domestic copper feedstocks to finished rod in days, not months. | |
 Red Points | Company operating in Cybersecurity. | |
 Red Queen Bio | Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense. | |
 Red Sift | Company operating in Cybersecurity. | |
 Redactive | Cybersecurity company. | |
 Redapto | | |
 Redbird | | |
 RedBrick AI | | |
 Redcar | Company operating in AI. | |
 Redcliffe Lifetech | | |
 Redcoat AI | Company operating in Cybersecurity. | |
 Reddit | Social news and discussion platform founded in 2005 by Steve Huffman and Alexis Ohanian. | San Francisco, California |
 Reddit, Inc. | | |
 Redis | | |
 Redis Labs | | |
 Redlist | Provides industrial maintenance software for asset management, lubrication programs, equipment inspections and safety compliance, with mobile workflows and AI assistance. | |
 RedoxBlox | Company operating in Climate & Energy. | |
 Redpanda | | |
 Reduced Energy Microsystems | | |
 Reducto | Reducto operates in AI. | |
 Redwood Materials | Climate & Energy company. | |
 Redwood Neuro | Redwood Neuro Inc. is an Irvine, California biotechnology company developing ultrasensitive blood-based biomarker assays for Alzheimer's disease and other disease-detection applications. Its NIH-supported SiMoLiSA research aims to create an accessible multiplex assay for Alzheimer's biomarkers and validate it using clinical samples. NIH's National Institute on Aging awarded the company USD506,061 in September2025 for a PhaseI SBIR project led by Murat Baday with co-investigator Ahmet Ali Yanik. These published research affiliations are recorded without assuming executive titles or full-time employment. The company's website describes diagnostic performance ambitions, but clinical approval, validated15-year prediction, commercial effectiveness and undisclosed private financing are not independently established by the sources reviewed. No public executive directory or named private investors were found. | Irvine, California, United States |
 Reelables | | |
 ReelSurfer | | |
 ReEmerge | ReEmerge, Inc. is an Edina, Minnesota medical-technology company developing Cognitive Network Restoration Therapy (CNRT) for persistent cognitive impairment after traumatic brain injury. Its deep-brain-stimulation approach targets the central thalamus and underperforming neural circuits involved in attention and executive function. The company licenses foundational intellectual property developed through research at Weill Cornell Medicine, with scientific collaborators at Stanford and the University of Utah. CNRT is investigational and has no commercial approval. ReEmerge’s current website names four executive leaders and four scientific co-founders: Nicholas Schiff, Jaimie Henderson, Jonathan Baker and Christopher Butson. It announced a closed USD37 million Series A on September15,2026, co-led by U.S. Venture Partners and Santé, with Oxford Science Enterprises, 415 Capital, IAG Capital Partners, The Vertical Group and Dendrion Ventures participating. Proceeds support a multicenter traumatic-brain-injury clinical study, technology development and clinical and regulatory operations. The company’s founding year and earlier cash-financing history remain unverified; university translational support and licensing are not presumed company equity investments. It is distinct from the Maryland career-coaching business ReEmerge, LLC. | Edina, Minnesota, United States |
 Reev | Reev develops powered knee orthoses that use sensors and AI to assist walking for people with neurological gait disorders. | |
 reevo | Reevo is the AI-native sales platform for prospecting, outreach, deal management, forecasting, coaching, and CRM powered by the full context of your business. | |
 Refinery29 | Media & Entertainment company. | |
 Reflect Orbital | Company operating in Defense & Space. | |
 Reflection | Open frontier AI lab building large-scale reinforcement learning and LLM infrastructure for agentic reasoning. Founded by former DeepMind researchers. Based in New York. | New York, New York |
 Reflektive | | |
 Reflex | Reflex operates in Developer Tools. | |
 Reflex Robotics | Reflex Robotics builds general-purpose humanoid robots for industrial work, combining production hardware, remote supervision and learning software to improve autonomy over time. | |
 Reflexivity | Developer Tools company. | |
 Refold | Refold is an AI-powered, secure enterprise integrations platform. Refold AI Agents handle SAP/Oracle/Workday, brittle APIs, and custom logic with self-healing workflows, audit logs, and 1,000+ connectors. | |
 Reforged Labs | | |
 Reframe Financial | Marketing & Advertising company. | |
 Refurbed | Company operating in E-Commerce & Marketplace. | |
 Refute | Refute operates in Legal. | |
 Refy | Refy provides biomass trading, pricing and supply-chain finance services across Asia. It works with producers, physical traders and industrial buyers of palm kernel shells, rice husks, wood pellets, wood chips, bagasse and other residues. Its products include early payment for receivables, fixed-price offtake and supply contracts, inventory price hedges and index-linked pricing. These tools help suppliers manage working capital and price risk while buyers secure fuel for power plants, cement kilns and industrial boilers. Refy originally developed green asset project financing tools and now presents a specialist biomass market offering. | |
 Refyne | Company operating in Fintech. | |
 Regal.io | Marketing & Advertising company. | |
 Regatta Data | Regatta Data develops a distributed database for AI agents and modern applications, designed by veterans of enterprise storage and database systems. | |
 Regenera GmbH | Regenera is developing SpinoSave, an investigational regenerative therapy for spinal-cord injury that combines a patient’s own adipose-derived cells with a biodegradable hydrogel. The material is designed to be placed locally during surgery to provide a supportive environment for repair after injury. Its development combines biomaterials, tissue engineering and cell therapy; published research and regulatory designations support clinical translation, without establishing marketing authorization or approved clinical efficacy. Regenera GmbH is the Austrian group company headquartered in Vienna, registered in 2022. It holds the Swiss subsidiary Regenera SA and is the named sponsor of the European orphan designation for autologous adipose-derived stem cells intended to treat spinal-cord injury. The company reports an ILUM Tec seed investment announced in November 2022. | |
 Regenera SA | Regenera is developing SpinoSave, an investigational regenerative therapy for spinal-cord injury that combines a patient’s own adipose-derived cells with a biodegradable hydrogel. The material is designed to be placed locally during surgery to provide a supportive environment for repair after injury. Its development combines biomaterials, tissue engineering and cell therapy; published research and regulatory designations support clinical translation, without establishing marketing authorization or approved clinical efficacy. Regenera SA is the Lugano-based Swiss company in the Austrian–Swiss Regenera group, incorporated in 2021. Its parent’s published history says it became a wholly owned subsidiary of Regenera GmbH in July 2022. It participates in the group’s research and development and was incubated by the Università della Svizzera italiana Startup Centre. The Swiss company is legally distinct from the Austrian orphan-designation sponsor and direct ILUM investee. | |
 REGENT | Electric Seaglider wing-in-ground-effect vessels. Founders Fund investor. | North Kingstown, Rhode Island |
 Regent Craft | | |
 RegenX | RegenX developed a regenerative agriculture platform linking food and ingredient buyers with farmers in Southeast Asia. It combined access to buyers and better farm-gate economics with farming guidance, monitoring and traceability to encourage practices that improve soil health and reduce reliance on chemical inputs. Its work included coffee farming in Vietnam, with digital tools to record farm practices and support emissions reporting. The current 100×100 portfolio lists the investment as terminated; ongoing operations and current employment are not established by that historical portfolio record. | |
 RegGenome | RegGenome operates in Data & Analytics. | |
 Regie | AI company. | |
 Regulus | Regulus operates in Cybersecurity. | |
 Reindeer AI | Custom enterprise AI agents for high-volume digital operations such as payments, KYC/AML, and reconciliation. Tel Aviv. | Tel Aviv, Israel |
 Reindeer AI | | |
 Reiterate | Company operating in Fintech. | |
 Rekise Marine | Rekise Marine operates in Robotics & Automation. | |
 REKKI | REKKI connects restaurants with their suppliers, letting chefs browse products, place and track orders, chat in real time, and handle payments in one place. Suppliers use REKKI to streamline order intake and get paid faster, with AI‑powered tools that reduce errors and bad debt. | 🇬🇧 · UK |
 rekord | Rekord is an AI-native platform that enables financial institutions to design, scale, and monitor intelligent decision flows across underwriting, onboarding, compliance, and fraud. It unifies models, data, and policies to operationalize AI with guardrails and real-time observability. | 🇮🇪 · Ireland |
 Relace | Relace operates in Consumer. | |
 Relation Therapeutics | London-based technology-enabled biopharmaceutical company founded in 2019. Relation combines AI, human genetics, single-cell multi-omics, functional assays and patient-derived tissue data in a Lab-in-the-Loop platform to identify causal disease biology and develop medicines. Its current programmes span bone, cardiorenal, dermatology and rheumatology, with Osteomics supporting bone-disease research and its MORGAN cellular-biology foundation model introduced in 2026. The company has disclosed $25 million seed financing in 2022, $35 million additional seed financing in 2024 and $26 million additional financing in 2025. GSK’s separate $15 million equity investment is distinguished from commercial research payments; the equity component of Novartis’s $55 million mixed collaboration package is undisclosed. Relation’s published team includes executives, scientific advisers, and board members or observers. The former crypto/Web3 classification and relationlabs.ai URL were misattributed to this biotechnology issuer. | Regent’s Place, 338 Euston Road, London, United Kingdom |
 Relativity | Company operating in Legal. | |
 Relativity Space | Defense & Space company. | |
 Relay | Relay operates in Telecom. | |
 Relay | | |
 Relay Commerce | Company operating in E-Commerce & Marketplace. | |
 Relay.app | Relay.app operates in SaaS. | |
 Releaf Earth | | |
 Releaf Inc | | |
 ReleaseHub | | |
 Relevance AI | Relevance AI operates in AI. | |
 Relevium Medical | | |
 Reliable Robotics | Robotics & Automation company. | |
 Reliance Health | Company operating in Healthcare. | |
 Reliant AI | Company operating in AI. | |
 Relixir | Relixir operates in Healthcare. | |
 Relyance AI | Company operating in AI. | |
 Rematiq | Company operating in Manufacturing. | |
 remberg | Fintech company. | |
 Remedee Labs | Healthcare company. | |
 Remedial Health | | |
 Remedy | Company operating in Healthcare. | |
 Remedy Scientific | Remedy Scientific operates in Climate & Energy. | |
 Remento | Company operating in Consumer. | |
 Remepy | Remepy develops hybrid treatments that combine pharmaceuticals with digital therapeutics designed to influence biological pathways and improve treatment outcomes. | |
 Remerge | Mobile advertising technology company providing programmatic app retargeting and user acquisition. Its platform uses machine learning for bidding and audience modeling, including privacy-oriented acquisition workflows. | 🇩🇪 · Germany |
 Remesh | AI company. | Cleveland, OH, US |
 Remi | | |
 Remilk | | |
 Remind | Signal profile (re.Mind Capital)
re.Mind Capital
cb | Germany · United Kingdom |
 Remix Therapeutics | | |
 RemNote | RemNote operates in Education. | Wilmington, DE, US |
 ReMoni | ReMoni is the Danish AI and sensing technology company REMONI A/S, identified by its own website as CVR35212124, based in Skanderborg. It combines patented non-invasive clamp-on sensors with statistical models and artificial intelligence to monitor electricity, heating, cooling and water and optimize resource use in buildings and industrial systems. Products include Predictive Heat Optimization, EnergyXplorer and monitoring/control platforms; its research includes power-quality analysis, district heating and digital twins. The company website describes operational founding in2014, while the historical investor article says2013; this discrepancy is not resolved into an exact legal incorporation date. Its contact page separately identifies ReMoni Danmark A/S CVR39326345 and Romanian ReMoni Technologies RO S.R.L.; those operating entities are distinguished from this company profile. The public directory publishes leadership, commercial staff and three directors with authentic named photographs, but has conflicting leadership layouts: Anders Hjortsholm is listed as CCO while another block calls Anders Steen Mortensen CCO rather than Head of Building Optimization. Both published affiliations are retained with that uncertainty, without invented tenure dates. Capnova was a historical shareholder and announced its exit in2020 alongside Kenneth Iversen's reported DKK20M investment; the source does not separate secondary acquisition proceeds from new issuer cash. A September2020 announcement distinguishes an EUR480,000 Innobooster award from Kenneth's prospective EUR1,350,000 matching private investment; grant disbursement and completion of the matching investment are not established. CORDIS separately records REMONI A/S as a beneficiary of grant958600 with EUR637,087.50 net EU contribution, not the entire consortium's EUR1,708,193.75 grant or EUR2,239,943.75 project cost. Awards, future commitments and those aggregate budgets are not recorded as completed equity cash. | Skanderborg, Denmark |
 Remos Space Systems | Remos Space Systems develops software-defined satellite ground communications and ground-station infrastructure. Its Expedite and Hasten modems run on standard computing hardware, on premises or in the cloud, to handle satellite telemetry, telecommand and payload downlinks. The company also supplies turnkey ground stations and its Umoja platform for scheduling, automation and coordination across owned stations, third-party equipment and ground-station service networks. Its capacity-building programme combines ground communications, mission control, simulation infrastructure and training for space agencies, universities and emerging satellite programmes. Founded in Luleå in 2021, the company commercialises work originating at Luleå University of Technology. | |
 Remote | Remote operates in HR & Talent. | |
 Remuner | Company operating in HR & Talent. | |
 reMYND | reMYND NV is a clinical-stage Belgian biotechnology company developing oral small molecules for neurodegenerative diseases. Founded in 2002 as a KU Leuven spin-off, it is registered under Belgian enterprise number BE0476.910.101 and is based at Gaston Geenslaan 1, Leuven. Its Alzheimer’s programme investigates septin modulation to restore calcium homeostasis and synaptic function. Lead candidate REM392 is investigational; the September2026 announcement plans a Phase1b patient study for early2027. Earlier REM127 Phase2a findings and exploratory AI digital-twin analyses do not establish approval or a proven cure. The Huntington’s candidate REM949 and mitochondrial-dysfunction discovery work remain development programmes. In March2025, reMYND sold its contract-research business to InnoSer to focus on proprietary drug development; older homepage CRO text is superseded by that transaction announcement. CEO Floor Stam was appointed in September2024; Gerard Griffioen is CSO. The current public directory names five operating leaders/advisers and seven board members, with Floor appearing in both groups. Former chair Johan Cardoen died in2025. KU Leuven’s September2026 interview separately confirms Joris Winderickx remains a scientific adviser after leaving the founding board. Completed announced equity comprises EUR12M SeriesB in December2018 and an additional EUR12M second close announced January21,2021; EUR24M is their aggregate, not a third raise. Investor PMV also documents an earlier convertible loan and a2022 syndicate financing with undisclosed amounts. On September21,2026, the company announced EUR3.5M strategic support from ADDF for REM392; ADDF project20731238 reports USD4,122,340 funding over September15,2026–March15,2028. These are source-specific representations of one programme award, not two cash raises. Instrument, disbursement and paid equity are unpublished, so structured cash amounts remain unknown. VLAIO/IWT and Michael J. Fox Foundation historical grant support is documented separately from equity; unspecified grant totals, license payments and the CRO sale price are not invented. BNP Paribas Fortis Private Equity’s own original credentials separately document two earlier equity investments inSeptember2009 andMay2016, corroborating the current bank portfolio’s2009 entry. These historical financings have undisclosed company totals, individual tickets, exact closing/announcement days and priced-series stages. They are distinct from the later2018 and2021 SeriesB closes; no parentbank, subsidiary or advisor-only cash duplication is inferred. The official ARKimedes-Fonds year-end2009 report additionally identifies Fortis Private Equity Arkimedes as the historical investing vehicle and records EUR750,000 cumulative investments in reMYND through December31,2009. This cumulative portfolio history is not assigned as the individual September2009 check or a further company round. | |
 Render | Render operates in Infrastructure & Cloud. | |
 Rendin | Rendin operates in PropTech. | |
 Reneo | | |
 Renew | Company operating in Climate & Energy. | |
 Renew Financial | Company operating in Fintech. | |
 Renewabl | Company operating in Climate & Energy. | |
 Renewafi | Renewafi operates in Climate & Energy. | |
 RenoFi | Fintech company. | |
 RenoRun | Company operating in Construction. | |
 Renoster | | |
 Rent The Runway | | |
 Rentomojo | Rentomojo operates in Consumer. | |
 reonic | Reonic is a vertical software platform for renewable energy installers. By unifying lead capture, system design, simulation, digital proposals, and project management Reonic helps teams sell, size, and deliver solar, storage, and heat pump projects faster and more profitably. | 🇩🇪 · Germany |
 Reonomy | Company operating in PropTech. | |
 ReOrbit | ReOrbit operates in Defense & Space. | |
 Rephrase.ai | | |
 Repl It | Repl It operates in Enterprise Software. | |
 Replai | Replai operates in Marketing & Advertising. | |
 Replenish | | |
 Replenit | Company operating in SaaS. | |
 Replenysh | Company operating in Logistics & Supply Chain. | |
 Replica | Urban planning data from mobility. | |
 Replicate | | |
 Replicated | Replicated operates in Developer Tools. | |
 Replika | Company operating in AI. | |
 Replimune | | |
 Replimune Group | Replimune is a biotechnology company developing oncolytic immunotherapies intended to destroy tumors locally and activate durable systemic anti-tumor immune responses. | |
 Replit | | |
 Replit, Inc. | | |
 Replo | | |
 Reply.io | Sales-engagement and email-automation platform. | |
 Reprise | | |
 Republic | Fintech company. | |
 Reputation.com | Reputation.com operates in Marketing & Advertising. | |
 Request Finance | Request Finance operates in Fintech. | |
 Rerun | Rerun builds the data stack for Physical AI, with an open-source SDK and viewer to log, sync, and visualize multimodal data from robotics and computer vision in real time. Teams use Rerun to debug, explore, and share interactive views locally or at scale. | 🇸🇪 · Sweden |
 Rescue Forensics | | |
 RescueTime | | |
 ResearchGate | Scientific collaboration network. Series B led by Founders Fund (2012). | Berlin, Germany |
 Resend | | |
 Reserve | Reserve operates in Fintech. | |
 Reservoir | Crypto & Web3 company. | |
 Reshape Biotech | | |
 Resident | Company operating in Consumer. | |
 Residently | PropTech company. | |
 Resilience | Resilience operates in Biotech & Life Sciences. | |
 Resilience | | |
 Resilience | | |
 Resiquant | | |
 Resistant AI | Fintech company. | |
 Resoloon | Develops high-altitude balloon platforms for Earth observation. Its systems carry imaging and sensor payloads in the stratosphere, using atmospheric modeling and navigation software to collect detailed geospatial data over large areas. The company is developing monitoring applications for infrastructure, agriculture, environmental change, disaster response and security. | |
 Resolution Games | Resolution Games is a Stockholm based studio focused on creating virtual reality (VR) and augmented reality (AR) immersive experiences for all. | |
 Resolution Games AB | Gaming company. | |
 Resolve AI | Multi-agent system that operates across code, infrastructure, and telemetry to triage alerts, investigate incidents, and help with production debugging. | San Francisco, California |
 ResolveGrid | Develops AI-assisted field-service software that combines workflows, computer vision and expert guidance to help service teams diagnose problems and complete work. | |
 Resolyst | Resolyst operates in Healthcare. | |
 Reson8 | Reson8 operates in AI. | |
 Resonado Labs | Resonado Labs operates in Hardware & Semiconductors. | |
 Resonance | | |
 Resonant Link Medical | Medical-device company developing wireless power and data transfer for implantable devices, including neurostimulators and brain-computer interfaces. Its Aurion WPT platform supports battery-free and rechargeable implants. Spun out of Resonant Link in 2025; predecessor financing is kept separate. | |
 Resoniks | Manufacturing company. | |
 ResortPass | Travel & Hospitality company. | |
 ResoTher Pharma | ResoTher Pharma is a Danish clinical-stage biotechnology company developing peptide-based resolution therapies to modulate inflammatory responses in acute cardiovascular disease. Its exact legal entity is ResoTher Pharma A/S, CVR37852406, formerly styled ApS in historical financing announcements, based in Holte nearCopenhagen. Its lead investigational compound RTP-026 is an AnnexinA1-derived FPR2 agonist being studied as a potential cardioprotective treatment in patients with acute myocardial infarction; issuer-reported2026Phase2a findings are research results, not regulatory approval or established clinical effectiveness. The scientific programme originates in research at the WilliamHarveyResearchInstitute and QueenMaryUniversityofLondon. This is deep biotechnology/drug-development coverage; direct AIsoftware or neuroscience product claims are not established. Current own public management names CEOAndersKronborg, CFOHanneVissingLeth and CMOMortenLindJensen. The published board includes chairBeckiMorison, ThomasJonassen, JeppeØvliØvlesen, HenrikStage, MichaelØsterlundMadsen, SvenJacobson and RoderickFlower. External scientific advisers are distinguished from employees; ThomasJonassen is also explicitly listed asChiefScienceOfficer. Co-foundersThomasJonassen andJeppeØvlesen’s2017CSO/CFO roles and formerCEOLoneVeng are historical; old leadership posts are not used to overwrite current2026 management. A2017seed financing signed withCAPNOVA aslead has undisclosed cash amount; the November2019DKK16.5M combined financing comprises equity and three grants, so it is not entered as pure equity or additional cash on topof its grant components. A completedMay2021share issue raisedDKK38.8M. ExactEUproject grants and received advances are distinguished from roundedawardannouncements and are not duplicated. The2024signedannualreport provides legalidentity and historicalfunding evidence, while2025plannedshareissuance commitments are not assumed cashcloses. HunterCapitalRTO1’s March2026 reverse-takeover LetterofIntent remained an intended all-share transaction: itsSeptember30,2026 announcement extends theLOI throughDecember31,2026. ResoTher separately completedapproximatelySEK14.8M bridgefinancing announcedJuly6,2026; no investor allocation or plannedlargerRTO financing/valuation is inferred as paid issuer cash. No completed public listing or merger withHunter is asserted. | Holte, Denmark |
 Resourcify | Company operating in Climate & Energy. | |
 Resourcly | Company operating in Manufacturing. | |
 Respan | Infrastructure & Cloud company. | |
 ReSpark | Provides AI-assisted operations software for metal recyclers, covering ticketing, inventory, dispatch, pricing, accounting and logistics. Formed by the combination of GreenSpark and ReMatter in 2026. | |
 Respeecher | Professional AI voice generator for real production workflows, with free testing and flexible integration for studios and media teams. | Kyiv, Ukraine |
 Respond.io | Respond.io provides a customer conversation platform for businesses handling high volumes of consumer enquiries, sales and follow-up messages. It brings messaging channels, voice calls, email, customer history and CRM integrations into a shared workspace for human teams and autonomous AI agents. Its tools automate routing, campaigns and customer journeys, including answering questions, qualifying leads, updating CRM records and arranging bookings, so businesses can capture, convert and retain customers across channels. Founded as Rocketbots in Hong Kong in 2017, the company renamed itself respond.io in 2020 and is headquartered in Kuala Lumpur, Malaysia. | |
 Responsys | Responsys operates in Marketing & Advertising. | |
 Resq | Company operating in Logistics & Supply Chain. | |
 Resquared | | |
 ReStabilise | Company operating in Crypto & Web3. | |
 Restate | PropTech company. | |
 Restaurant365 | Restaurant365 operates in SaaS. | |
 Restorative Neurotechnologies | Restorative Neurotechnologies S.r.l. is an Italian neurotechnology and medical-software company developing cognitive rehabilitation tools that combine prismatic adaptation with digital exercises and clinician monitoring. Founded in Palermo in December2018 by neurologist and University of Palermo professor Massimiliano Oliveri and a clinical/software team, it operates in Palermo and Turin under Italian VAT IT06740010829. Its professional product MindLenses combines prism glasses, serious games and a clinical web portal for cognitive rehabilitation, particularly after stroke. The company publishes separate European device classifications by intended use: stroke rehabilitation ClassIIa and certain head-trauma/ADHD applications ClassI. These are issuer-reported CE-marking claims; its independently issued DNV ISO13485 quality-management certificate is distinct from a product marketing authorization. The company has described preparation for an FDA application, and no FDA clearance or approval is asserted. Investigated mild cognitive impairment, dementia and other indications are distinguished from established regulatory indications; patient-benefit claims are not presented as independent clinical conclusions. MindPAth is described separately as a consumer product. Its current directory lists founder Massimiliano Oliveri as CEO and board president,21 operating affiliations and three scientific-committee members; the2024 CEO LaurentVandebrouck affiliation is historical. A2019 EUR110000 SocialFare seed close,2020 EUR1M equity financing and November6,2024 EUR3M SeriesA are separately disclosed. EITHealth Headstart2019 awardedEUR40000, with actual disbursement unpublished. AdditionalEUR1M discussed in2024 was prospective, not an extra completed round. | Palermo, Italy · Turin, Italy |
 Restore Vision | Tokyo-based clinical-stage biotechnology company founded in 2016 that develops optogenetic gene therapies to restore vision lost through retinal degeneration. Its lead candidate RV-001 uses an AAV vector to deliver a gene encoding chimeric rhodopsin, a light-sensitive protein designed to make surviving retinal interneurons respond to light after photoreceptor loss. It is administered by intravitreal injection and is being evaluated in a Phase I/II trial for retinitis pigmentosa, with an approach intended to work across different causative genetic mutations. The technology originated in joint research at Keio University School of Medicine and Nagoya Institute of Technology. Restore Vision also develops additional retinal gene-therapy programs and manufacturing capabilities; its therapies remain investigational. | |
 Retab | Company operating in AI. | |
 RetailReady | | |
 Retell AI | | |
 Retirable | Company operating in Fintech. | |
 RetiSpec | RetiSpec is a Toronto-based medical AI company developing retinal imaging to detect biomarkers associated with Alzheimer’s disease and other neurodegenerative conditions. Its hyperspectral eye imaging and AI algorithms aim to predict brain amyloid burden through a non-invasive eye exam, supporting research into earlier detection and more accessible screening. The company works with clinical and research partners to validate its technology and advance commercialisation. Founded in 2016, RetiSpec’s technology is currently available for research use only; its retinal assessment is not presented as an approved routine diagnostic test. | |
 Retool | | |
 Retool | | |
 Retraced | Company operating in Logistics & Supply Chain. | |
 Retro | Retro operates in PropTech. | |
 Reunion Neuroscience | Reunion Neuroscience is a Morristown, New Jersey clinical-stage biotechnology company developing psychedelic-inspired treatments for mental health disorders. Its lead investigational drug, luvesilocin (formerly RE104), is a patented prodrug of 4-OH-DiPT that targets the serotonin 2A receptor and is designed for subcutaneous administration with a shorter acute psychedelic experience. The company is studying postpartum depression, adjustment disorder and generalized anxiety disorder. It reported positive Phase 2 postpartum depression results and received FDA Breakthrough Therapy Designation in February 2026; the drug remains investigational. Reunion became privately held after its acquisition by an MPM BioImpact affiliate in 2023. Its Series A financing, initially announced at USD103 million in May 2024, reached USD133 million at the final tranche closing in September 2025. Sahil Kirpekar became President and CEO in June 2026. | |
 Revalia | We're using AI to transform donated human organs & tissues into high-fidelity biological data, shared insight, and faster decisions. | |
 revalia-bio | Company operating in Biotech & Life Sciences. | |
 Revcast | SaaS company. | |
 Reveal HealthTech | Reveal HealthTech is a US and India healthcare AI and engineering company that develops software and data systems for healthcare providers, life-sciences organizations and medical-device businesses. It combines clinical expertise, product design, engineering, strategic advisory and implementation support to build and deploy tailored AI systems. Its BioCanvas offering supports multimodal life-sciences data workflows, including clinical-trial recruitment and oncology research, while Prism AI supports workflow automation with intelligent agents. Its applied AI lab explores patient engagement, product design and care-delivery use cases with research and prototyping partners. Founded in 2023 and incubated by W Health Ventures and 2070 Health, the company expanded through the combination with Manifold’s AI consulting division in 2024. Its current legal footer identifies Reveal HealthTech, Inc.; its engineering operations span the US and India. | |
 Reveal Technology | Reveal Technology operates in Cybersecurity. | |
 Revel | Mobility & Transportation company. | |
 RevEng.AI | London cybersecurity company founded by James Patrick-Evans in 2023, developing specialised AI for reverse engineering, binary analysis and software supply-chain verification. RevEng.AI analyses compiled executables, firmware and third-party software without source-code access to help security teams identify hidden functionality, malicious components, vulnerabilities and suspicious changes between releases. Its original BinNet approach has expanded into the Mega Bite model suite: WilBERT learns function similarity across binaries and architectures, while Ventris reconstructs readable code from compiled software. The product combines malware analysis, code search, decompilation and security workflows, with integrations for tools such as Ghidra and IDA and developer SDKs. Published benchmark results are company evaluations, with stated limits on semantic equivalence and architecture coverage. Known leadership includes Founder and CEO James Patrick-Evans, Lead ML Research Scientist Henry Charlesworth, Head of Engineering Robert Marsal and Head of Defence & Partnerships Jonny P. The company announced a $4.15 million seed round in June 2025 and a $15 million Series A in May 2026, following an earlier pre-seed of undisclosed amount and date. NCSC for Startups and Intel Ignite participation are accelerator support, distinct from equity funding. Its current website identifies UK company number 14818671; secondary records for an older dissolved entity should not be treated as its current operating status. | Kings Cross, London, United Kingdom |
 RevenueCat | | |
 Rever | | |
 Reverse Supply | Provides resale services for apparel brands, handling collection, quality checks, pricing and logistics for secondhand products. | |
 Revery AI | | |
 Revionics | Company operating in SaaS. | |
 Revolut | Revolut is the leading global neobank. Founded in London in 2015, Revolut has become a global financial super app, unifying everyday money management – spend, send, save, invest, and business finances – in a single platform. | 🇬🇧 · UK |
 Revoy | | |
 RevSure | Company operating in SaaS. | |
 Revterra | Develops flywheel energy storage systems using superconducting bearing technology for grid resilience, electric vehicle charging, data centers and industrial power applications. | |
 Revv | Revv developed electronic-signature and document-automation software for small and midsize businesses; it was acquired in 2022. | |
 Revyl | | |
 Revyze | | |
 Rewind | Rewind operates in Developer Tools. | |
 Rewire | | |
 Rewire AI | Rewire AI is a Portland, Oregon-based biomedical computer-vision company spun out of Washington State University. Previously branded Rewire Neuro and Rewire Neuroscience, it announced the Rewire AI name in April 2023; its current website identifies the business as Rewire Neuro, Inc. Its Polygon AI image-analysis software, previously Pipsqueak Pro, and Sightologist.ai inference engine automate cell and biomarker detection and quantification in microscopy images, with custom machine-learning models and integrations for research and diagnostic-device partners. Founder and CEO John Harkness trained in behavioral neuroscience; Kristy Lawton is its scientific lead. Partnerships include Neurescence for neuronal image analysis and eLabNext for laboratory workflow integration. Documented support includes NIH SBIR and STTR research grants, Business Oregon grants, an Angel Oregon Tech investment and pre-seed backing from Elevate Capital. NIH records identify the recipient under the earlier name Rewire Neuroscience, LLC, with John H. Harkness as principal investigator. These research awards are distinct from equity financing. Company releases describe a 2019 founding, while university materials document the earlier neuroscience startup and technology origins. The current public sources do not establish a complete employee roster or clinical approval for its software. | |
 Reworkd | Enterprise Software company. | |
 REXS.io | Early blockchain-interoperability project that developed a business platform for exchanging data and services across enterprise and distributed-ledger systems. | |
 Reyedar | Reyedar develops SONDA, an eye-tracking platform that measures visual function while a patient follows a moving target. Wearable infrared sensors record gaze and eye movement, and its software analyzes the signals to produce a clinical visual-function report without button presses. The system combines eye-movement perimetry and oculomotor assessment for use in optometry practices and ophthalmology clinics. Reyedar identifies SONDA software as a CE-marked Class IIa medical device under the EU Medical Device Regulation, intended to detect visual function loss as an aid in diagnosing and staging primary open-angle glaucoma in adults; the hub is Class I hardware. Its functional oculomics research investigates eye-movement biomarkers in conditions such as spinocerebellar ataxia and acquired brain injury. Those applications remain research and are outside SONDA’s cleared clinical use. Reyedar B.V., formerly Reperio Medtech, is a spin-off of the University Medical Center Groningen. | Groningen, Netherlands |
 Rezera | Develops oral NLRP3 inflammasome inhibitors intended to reduce chronic inflammation in cardiovascular and neurological diseases. Its pipeline includes ruvonoflast for peripheral artery disease and brain-penetrant trabzanoflast. The company was formerly called NodThera. | |
 Rhea | Rhea operates in Healthcare. | |
 Rhino | Company operating in Mobility & Transportation. | |
 Rhoda AI | Develops video-trained foundation models for general-purpose robots, enabling machines to learn physical tasks and operate in industrial settings. | |
 Rhovica Neuroimaging | Rhovica Neuroimaging is a Bern-based medical technology company founded by neurosurgeons Martin Hlavica and Thomas Rhomberg. It develops SoNav, a sensor-based system for real-time bedside visualization and navigation during external ventricular drain catheter insertion in emergency neurosurgery. Its technology is also intended to support subsequent monitoring of brain ventricles. | |
 RhyGaze AG | | |
 Rhythm NewMedia | | |
 Ribbon | Company operating in PropTech. | |
 Ribbon Health | Ribbon Health operates in Healthcare. | |
 Ribbon Home | Company operating in PropTech. | |
 RiboGene | | |
 Ribon Therapeutics | | |
 Richmond National Group, Inc. | | |
 Ricursive Intelligence | Frontier AI lab focused on building self-improving systems, starting with chip design. Reinventing chip development and closing the loop between AI and the hardware that fuels it. | Palo Alto, California |
 Ride Therapeutics | Cambridge biotechnology company developing AI-designed, non-viral delivery carriers for genetic medicines. Its Molecular Logistics platform combines high-throughput nanoparticle engineering and in-vivo screening with a generative model trained on biodistribution measurements. The company reports delivery hits across multiple tissues, including brain and lung; its cystic fibrosis delivery program remains preclinical. Ride emerged from Harvard and Cambridge research, with a UK entity incorporated in 2022 and a public launch in 2023 backed by $8 million in seed funding. In September 2026 the Cystic Fibrosis Foundation announced a commitment of up to $7.3 million for lung delivery development. That conditional commitment is distinct from seed cash already raised. | Cambridge, England, United Kingdom |
 Ridecell | | |
 RideCell, Inc | Ridecell provides fleet intelligence and automation software that helps mobility operators and vehicle fleets manage assets, operations and digital transformation. | |
 RideCo | Mobility & Transportation company. | |
 Ridekick | Develops an AI car-buying agent that contacts dealerships for itemized written prices while keeping buyers’ personal contact information private. | |
 Ridepanda | Mobility & Transportation company. | |
 Ridepanda | | |
 Rider | | |
 Riff | Oslo enterprise vibe-coding platform. Series A ~€14M with Founders Fund. | Oslo, Norway |
 Rigetti | Rigetti operates in Hardware & Semiconductors. | |
 Rightfoot | Rightfoot operates in Fintech. | |
 RightHand Robotics | Company operating in Robotics & Automation. | |
 Rightway | Company operating in Healthcare. | |
 Rigi | Rigi operates in Travel & Hospitality. | |
 RigUp | | |
 Riiico | Manufacturing company. | |
 Riley | | |
 Rilian | Rilian operates in Cybersecurity. | |
 Rilian Technologies | Rilian Technologies operates in Cybersecurity. | |
 Rill Data | Data & Analytics company. | |
 Rillet | Enterprise Software company. | New York, NY, US |
 Rimac Automobili | Porsche has increased its stake in technology and sports car company Rimac Automobili to 15.5 percent. In June 2018, the Stuttgart-based sports car manufacturer purchased a 10 percent stake in Rimac. The details. | |
 Rime Labs | Company operating in AI. | |
 RIME Therapeutics | RIME Therapeutics is a Montreal biotechnology company developing an AI-assisted drug-discovery platform. Its function-first Disruptide platform uses AI-designed peptide probes to screen intracellular protein pockets in primary human cells. The approach links changes in disease-relevant cell biology to specific targets while generating binding and structure-activity data to guide subsequent drug chemistry. RIME combines human genetics, perturbation biology and machine learning to identify potential new therapeutic programs, initially including inflammation and immunology. Its published work is at the discovery-platform stage; it has not disclosed an approved medicine. | Montreal, Canada |
 Ring | Ring makes connected home-security products, including video doorbells, indoor and outdoor cameras, alarms and motion-activated lighting. Its app lets customers see and communicate with visitors and monitor their homes remotely. | |
 Ringly | Ringly operates in Consumer. | |
 Rinse | Company operating in Consumer. | |
 Rinsed | Car-wash CRM. | |
 Riogrande | | |
 Riot | | |
 Ripcord | Company operating in Robotics & Automation. | |
 Rippl | Healthcare company. | |
 Ripple | Ripple operates in Food & Agriculture. | |
 Ripple | | |
 Ripplematch | Company operating in HR & Talent. | |
 Rippling | HR, IT, and payroll operating system for businesses. Founded 2016. San Francisco. | San Francisco, California |
 Rippling | | |
 Rippling | | |
 Risa | Fintech company. | |
 Risa | | |
 RISC Zero | RISC Zero operates in Cybersecurity. | |
 Risc0 | | |
 Rise Gardens | Rise Gardens makes indoor hydroponic gardening systems for growing herbs, vegetables and other produce at home. Its connected gardens combine lighting, water circulation and app-based guidance to help users grow food year-round. | |
 Rise Reforming | | |
 Risilience | Company operating in Climate & Energy. | |
 riskmethods | Founded in 2013 in Munich, riskmethods provides supply chain risk management software that continuously monitors global threats, scores supplier exposure, and guides mitigation to keep operations resilient and compliant. The company was acquired by Sphera in 2022. | 🇩🇪 · Germany |
 Risotto | | |
 Ritual | Subscription women's daily vitamin. | Los Angeles, California |
 Rivan | Company operating in Climate & Energy. | |
 Rive | | |
 River Financial | Bitcoin financial services. | |
 River Markets | | |
 Riverbed Technology | | |
 Riverlane | Riverlane operates in Climate & Energy. | |
 RiverPool | | |
 Riverse | Company operating in Climate & Energy. | |
 Rivet | Company operating in Manufacturing. | |
 Rivia | Biotech & Life Sciences company. | |
 Rivus Batteries | Rivus Batteries is the Gothenburg company Rivus AB, developing aqueous organic electrolytes for stationary flow batteries. Its chemistry stores energy using organic molecules, water and salts rather than critical-metal electrolytes such as vanadium, with the goal of supporting long-duration renewable-energy storage and more resilient supply chains. It designs the electrolytes to work with existing commercial flow-battery hardware and industrial chemical production, rather than requiring proprietary battery stacks. Its commercialization effort began in early 2023, following research at Chalmers, the University of Turku and the Technical University of Denmark. The company is advancing chemical scale-up, stack testing and customer pilots during 2026–2027; its 2028 large-scale deployment objective is a target. Lower costs, safety and performance advantages are company development claims, rather than independently proven outcomes of widespread commercial deployment. | |
 Rivus Pharma | | |
 Rivus Pharmaceuticals | | |
 Riya Collective | | |
 Riyadh Valley Company | Riyadh Valley Company (RVC) is the commercial knowledge-economy and strategic-project investment arm of King Saud University in Riyadh, Saudi Arabia. Its own institutional history records establishment in2010 by Royal Decree No.116 dated13/4/1431AH. It invests locally and internationally in growth-stage businesses to generate financial and strategic returns and connect university research and capabilities with commercial investment. The public royal-decree history establishes its university-company identity; an exact commercial-registration number and share-capital amount have not been independently verified. It is represented as a corporate Company investor, rather than an external private venture-fund manager.
The venture portfolio spans biotechnology and healthcare, information and communications technology, sustainable resources, fintech, logistics and education. RVC also backs third-party venture funds, including deep-tech Abies Ventures FundII, and develops university-land projects for research, education, healthcare and other uses. Those investee funds are not RVC-managed fund closes. Its direct neuroscience relevance is the company’s own March25,2021 announcement of an investment in Australian Global Kinetics PtyLtd, developer of the Personal KinetiGraph objective Parkinson’s movement-monitoring system; ticket, stage and exact paying vehicle are unpublished. Corporate capital, university land, programme budgets and third-party fund targets are not asserted as new LP-fund cash raises. No RVC-managed closed LP vehicle has been verified.
All seven currently published board members and nine published committee appointments are represented, with overlap retained as separate governance roles. CEO Khalid Al-Saleh is last explicitly confirmed by RVC in its September25,2025 investment release and by the university’s own industrial-engineering biography; continuing tenure beyond the last dated confirmation is qualified. This is the complete accessible named governance roster plus that source-confirmed executive, rather than a claimed census of private employees. Ten distinct authentic own-governance portraits and Khalid’s authentic university portrait are recorded. The website incorrectly repeats the same asset for Andrea Longhi, Faisal Alyemni and Sara Alhusaini; these three images are withheld pending identity-confirmed portraits. Exact director appointment dates and unpublished broader biographies remain unknown. The earlier May2025 chairman is not substituted for the current published chairman. | Riyadh, Saudi Arabia |
 Rize | Rize provides technology, agronomy support, financing access and market connections for rice farmers in Southeast Asia. It helps farmers adopt practices such as alternate wetting and drying, improved fertiliser use, lower pesticide inputs and crop residue management to reduce emissions and water use while improving farm economics. Its digital platform supports farmer onboarding, input and repayment tracking, agronomist decisions and measurement of environmental outcomes. Rize also connects low-emission rice to buyers through field-level traceability, building an integrated infrastructure for sustainable rice production in Vietnam, Indonesia and other markets. | |
 Rizm | RIZM's software platform integrates data from production, energy procurement, and infrastructure to algorithmically optimize industrial energy systems. Founded in 2020, RIZM helps manufacturers cut costs, reduce emissions, and stay resilient amid energy market volatility. | 🇩🇪 · Germany |
 RJMetrics | | |
 RMFG | Manufacturing company. | |
 RNatives | RNatives develops investigational RNA medicines that regulate gene expression to address serious diseases. Its RNAIntel platform uses artificial intelligence, machine learning and genomic datasets to find small non-coding RNAs that can activate or silence genes, then validates selected candidates in laboratory experiments. The Finnish biotechnology company is developing precision therapies for ocular and metabolic diseases and cancer, with earlier published work also discussing cardiovascular and central nervous system applications. The underlying research uses RNA interactions to induce epigenetic changes that can have lasting effects on gene expression. | |
 Ro | Ro operates in Healthcare. | |